Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment

Mise à jour : Il y a 4 ans
Référence : NCT02101190

Femme et Homme

Extrait

The purpose of this study is to assess the pharmacokinetics (PK) of BIA 9-1067 in patients with moderate chronic hepatic impairment and in matched healthy subjects.


Critère d'inclusion

  • Parkinson's disease

Liens